Lymphoma News Archives > Lymphoma Research Foundation

U.S. Food and Drug Administration Approves Acalabrutinib (CALQUENCE) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

U.S. Food and Drug Administration Approves Zanubrutinib (BRUKINSA) for Mantle Cell Lymphoma (MCL)

U.S. Food and Drug Administration Approves Pegfilgrastim-bmez (Ziextenzo) for Long-Acting Oncology Supportive Care

Lymphoma Research Foundation Update on Vincristine Supply

U.S. Food and Drug Administration Requests Voluntary Recall of Textured Implants Linked to Breast Implant-Associated Anaplastic Large Cell Lymphoma

U.S. Food and Drug Administration Approves Biosimilar Rituximab-pvvr (Ruxience) for CD20-positive non-Hodgkin B-cell Lymphomas and Chronic Lymphocytic Leukemia

U.S. Food and Drug Administration Approves Polatuzumab Vedotin-Piiq (Polivy) for Diffuse Large B-Cell Lymphoma

U.S. Food and Drug Administration Approves Chemo-Free Therapy for Relapsed/Refractory Indolent Lymphomas

U.S. Food and Drug Administration Approves Ruxolitinib (JAKAFI) for Acute Graft-Versus-Host Disease

FDA Approves Chemo-Free Frontline Regimen for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)